Lineage specific cells and phogenitor cells

Abstract

A method for generating a culture that is purified or enriched in respect of cells of a selected lineage is described in which a selectable marker, which is differentially expressed in cells of the selected lineage compared with its expression in other cells, is introduced into a multipotential cell and the multipotential cell is cultured to induce differentiation of the multipotential cell into a cell of the selected lineage or into a mixture of cells including cells of the selected lineage, or is cultured to induce preferential survival of cells of the selected lineage. Those cells that express the selectable marker are then selected for. Progenitors of selected lineage are also described as is the use of the method in assay techniques.

1 . A method for generating a culture that is purified or enriched in neural progenitor cells, comprising: 
 (i) introducing into a pluripotent cell a selectable marker that is differentially expressed in neural progenitor cells compared with its expression in other cells, wherein neural progenitor cells constitute a sub-set of the cells obtainable from the pluripotent cell, and wherein expression of the selectable marker is under the control of a promoter of a gene that is differentially expressed in neural progenitor;    (ii) culturing the pluripotent cell in vitro in the presence of a factor that induces differentiation of the pluripotent cell to induce differentiation of the pluripotent cell into a neural progenitor cell or into a mixture of cells including neural progenitor cells, or to induce preferential survival, in a mixed culture of cells, of neural progenitor cells; and    (iii) selecting for neural progenitor cells according to differential expression of the selectable marker introduced in step (i).    
     
     
         2 - 41 . (canceled)  
     
     
         42 . The method of  claim 1 , wherein the factor is retinoic acid.  
     
     
         43 . The method of  claim 1  wherein the pluripotent cell is selected from the group consisting of embryonic stem (ES) cells, embryonic germ (EG) cells, embryonic carcinoma (EC) cells, a primary culture of fetal cells, a primary culture of post-natal cells, and a primary culture of adult cells.  
     
     
         44 . The method of  claim 1 , comprising genetically modifying plurtipotent cells by deleting, mutating, substituting, or adding genes in said pluripotent cells in order to assay gene function in neural progenitor cells, or to render selected cells more suitable for transplantation, or both.  
     
     
         45 . The method of  claim 1 , further comprising: 
 (iv) introducing into the pluripotent cell a second selectable marker that is differentially expressed in cells of a selected sub-lineage compared with its expression in other cells, wherein cells of the selected sub-lineage are formed by differentiation of neural progenitor cells; and    (v) when a culture of neural progenitor cells has been obtained, allowing or inducing differentiation of the cells and selecting for cells that express the second selectable marker.    
     
     
         46 . The method of  claim 1 , wherein the selectable marker is introduced into the pluripotent cell by targeted integration or random gene trap integration so as to be operatively coupled to a gene that is differentially expressed in neural progenitor cells.  
     
     
         47 . The method of  claim 1 , wherein the selectable marker is introduced into the pluripotent cell via random integration of a transgene in which the selectable marker is operatively coupled to a gene that is differentially expressed in neural progenitor cells.  
     
     
         48 . The method of  claim 1 , wherein the multipotential cell is an ES, EG, or EC cell and the method comprises forming an embryoid body in step (ii), or otherwise inducing differentiation of the cells.  
     
     
         49 . The method of  claim 48 , wherein the differentiated cells are dissociated so as to form a culture substantially of individual cells.  
     
     
         50 . The method of  claim 48 , wherein differentiated cells of an embryoid body are dissociated using a protease.  
     
     
         51 . The method of  claim 1 , wherein the selectable marker is an antibiotic resistance gene and the method comprises culture in the presence of antibiotic.  
     
     
         52 . The method of  claim 45 , for obtaining a culture that is purified or enriched in ventral progenitor cells, wherein the selectable marker is differentially expressed in neural progenitor cells and the second selectable marker is differentially expressed in ventral progenitor cells.  
     
     
         53 . The method of  claim 52 , wherein the second selectable marker is differentially expressed in cells that express Pax 6.  
     
     
         54 . The method of  claim 1 , wherein expression of the selectable marker is operatively linked to expression of a gene selected from the group consisting of Pax 3, delta-1, Mash-1, Math 4a, Pax 6, β-tubulin, synapsin-1, MAP2/tau, GFAP, GABA, and islet-1/2.  
     
     
         55 . The method of  claim 1 , further comprising freezing the cell in the presence of a cryoprotectant.  
     
     
         56 . The method of  claim 1 , further comprising culturing the neural progenitor cells obtained in the presence of medium suitable for differentiation of the neural progenitor cells into neurons.  
     
     
         57 . A method for generating a culture that is purified or enriched in neural progenitor cells, comprising: 
 (i) obtaining a pluripotent cell which comprises a nucleotide sequence encoding a selectable marker under the control of a promoter of a gene that is differentially expressed in neural progenitor cells compared with its expression in other cells, wherein neural progenitor cells constitute a sub-set of the cells obtainable from the pluripotent cell;    (ii) culturing the pluripotent cell in vitro in the presence of a factor that induces differentiation of the pluripotent cell so as to induce differentiation of the pluripotent cell into a neural progenitor cell or into a mixture of cells including neural progenitor cells, or to induce preferential survival, in a mixed culture of cells, of neural progenitor cells;    (iii) selecting for neural progenitor cells according to differential expression of the selectable marker; and    (iv) propagating the neural progenitor cells obtained in (iii).    
     
     
         58 . The method of  claim 57 , further comprising inducing differentiation of the propagated neural progenitor cells of (iii) into neurons.  
     
     
         59 . The method of  claim 57 , further comprising inducing differentiation of the propagated neural progenitor cells of (iii) into glia.  
     
     
         60 . A pluripotent cell comprising a sequence encoding a selectable marker operatively linked to a promoter of a gene selected from the group consisting of sox-1, sox-2, sox-3, Pax 3, delta-1, Mash-1, Math 4a, Pax 6, β3-tubulin, synapsin-1, MAP2/tau, GFAP, GABA and islet-1/2.  
     
     
         61 . The cell of  claim 60 , which is a human cell.  
     
     
         62 . The cell of  claim 60 , which is a mouse cell.  
     
     
         63 . A neural cell comprising a sequence encoding a selectable marker operatively linked to a promoter of a gene selected from the group consisting of sox-1, sox-2, sox-3, Pax 3, delta-1, Mash-1, Math 4a, Pax 6, β-tubulin, synapsin-1, MAP2/tau, GFAP, GABA and islet-1/2.  
     
     
         64 . The cell of  claim 63 , which is a human cell.  
     
     
         65 . The cell of  claim 63 , which is a mouse cell.